Western blot analysis of extracts from various cell lines using HDAC4 (D8T3Q) Rabbit mAb.
Immunoprecipitation of HDAC5 from 293T cell extracts. Lane 1 is 10% input, lane 2 is Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, and lane 3 is HDAC5 (D1J7V) Rabbit mAb. Western blot analysis was performed using HDAC5 (D1J7V) Rabbit mAb.
Western blot analysis of extracts from HeLa and Jurkat cells using HDAC6 (D21B10) Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using HDAC7 (D4E1L) Rabbit mAb.
After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO® is added and emits light during enzyme catalyzed decomposition.
Western blot analysis of extracts from various cell lines using HDAC5 (D1J7V) Rabbit mAb.
Western blot analysis of extracts from C2C12 cells, wild-type mouse embryonic fibroblasts (MEFs), and HDAC6 (-/-) MEFs using HDAC6 (D21B10) Rabbit mAb (upper) or β-Actin (13E5) Rabbit mAb #4970 (lower).
Immunohistochemical analysis of paraffin-embedded K-562 (left) and LNCaP (right) cell pellets using HDAC7 (D4E1L) Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded human ovarian carcinoma using HDAC7 (D4E1L) Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right).
Immunohistochemical analysis of paraffin-embedded human tonsil using HDAC7 (D4E1L) Rabbit mAb.
Western blot analysis of extracts from various cell lines using HDAC7 (D4E1L) Rabbit mAb.
|HDAC4 (D8T3Q) Rabbit mAb 15164||20 µl||
||H M R Mk||140||Rabbit IgG|
|HDAC5 (D1J7V) Rabbit mAb 20458||20 µl||
||H M R Mk||140||Rabbit IgG|
|HDAC6 (D21B10) Rabbit mAb 7612||20 µl||
||H M R||160||Rabbit IgG|
|HDAC7 (D4E1L) Rabbit mAb 33418||20 µl||
||H M Mk||124||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody 7074||100 µl||
The Class II HDAC Antibody Sampler Kit provides an economical means of detecting Class II HDAC proteins using control antibodies against HDAC4, HDAC5, HDAC6, and HDAC7. The kit contains enough primary antibodies to perform at least two western blot experiments.
Each antibody in the Class II HDAC Antibody Sampler Kit detects endogenous levels of its target protein. Cross-reactivity was not observed with other family members.
Monoclonal antibodies are produced by immunizing rabbits with synthetic peptides corresponding to the amino terminus of human HDAC4, Leu445 of human HDAC5, the carboxy terminus of HDAC6, and Leu66 of HDAC7 proteins.
Acetylation of the histone tail causes chromatin to adopt an "open" conformation, allowing increased accessibility of transcription factors to DNA. The identification of histone acetyltransferases (HATs) and their large multiprotein complexes has yielded important insights into how these enzymes regulate transcription (1,2). HAT complexes interact with sequence-specific activator proteins to target specific genes. In addition to histones, HATs can acetylate nonhistone proteins, suggesting multiple roles for these enzymes (3). In contrast, histone deacetylation promotes a "closed" chromatin conformation and typically leads to repression of gene activity (4). Mammalian histone deacetylases can be divided into three classes on the basis of their similarity to various yeast deacetylases (5). Class I proteins (HDACs 1, 2, 3, and 8) are related to the yeast Rpd3-like proteins, those in class II (HDACs 4, 5, 6, 7, 9, and 10) are related to yeast Hda1-like proteins, and class III proteins are related to the yeast protein Sir2. Inhibitors of HDAC activity are now being explored as potential therapeutic cancer agents (6,7).
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST's products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST's Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.